[Translated article] Locally Advanced Cutaneous Squamous Cell Carcinoma Treated With Immunotherapy in a Dermatology Department
Open Access
- 27 January 2023
- journal article
- letter
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 114 (3) , T285-T287
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaEuropean Journal of Cancer, 2021
- Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trialAnnals of Oncology, 2021
- Immunotherapy for the Treatment of Cutaneous Squamous Cell CarcinomaFrontiers in Oncology, 2021
- Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter studyEuropean Journal of Cancer, 2020
- Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trialThe Lancet Oncology, 2020
- Evaluation of T‐lymphocyte subpopulations in actinic keratosis, in situ and invasive squamous cell carcinoma of the skinJournal of Cutaneous Pathology, 2018